BeiGene Ltd. (ONC)
BeiGene Statistics
Share Statistics
BeiGene has 116.3M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 116.3M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.6M, so 1.48% of the outstanding shares have been sold short.
| Short Interest | 1.6M |
| Short % of Shares Out | 1.48% |
| Short % of Float | 2.13% |
| Short Ratio (days to cover) | 3.88 |
Valuation Ratios
The PE ratio is -30.16 and the forward PE ratio is 36.55. BeiGene's PEG ratio is -0.04.
| PE Ratio | -30.16 |
| Forward PE | 36.55 |
| PS Ratio | 5.1 |
| Forward PS | 4.4 |
| PB Ratio | 5.84 |
| P/FCF Ratio | -29.04 |
| PEG Ratio | -0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for BeiGene.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.8, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.8 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | -2.72 |
| Debt / FCF | -1.61 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $346.39K |
| Profits Per Employee | $-58.62K |
| Employee Count | 11,000 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 1.2 |
Taxes
| Income Tax | 111.78M |
| Effective Tax Rate | -20.97% |
Stock Price Statistics
The stock price has increased by 78.34% in the last 52 weeks. The beta is 0.49, so BeiGene's price volatility has been higher than the market average.
| Beta | 0.49 |
| 52-Week Price Change | 78.34% |
| 50-Day Moving Average | 246.48 |
| 200-Day Moving Average | 207.69 |
| Relative Strength Index (RSI) | 45.19 |
| Average Volume (20 Days) | 519K |
Income Statement
In the last 12 months, BeiGene had revenue of 3.81B and earned -644.79M in profits. Earnings per share was -6.11.
| Revenue | 3.81B |
| Gross Profit | 3.22B |
| Operating Income | -568.2M |
| Net Income | -644.79M |
| EBITDA | -396.44M |
| EBIT | -568.2M |
| Earnings Per Share (EPS) | -6.11 |
Balance Sheet
The company has 2.63B in cash and 1.08B in debt, giving a net cash position of 1.55B.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 1.08B |
| Net Cash | 1.55B |
| Retained Earnings | -8.61B |
| Total Assets | 5.92B |
| Working Capital | 1.78B |
Cash Flow
In the last 12 months, operating cash flow was -140.63M and capital expenditures -529.14M, giving a free cash flow of -669.77M.
| Operating Cash Flow | -140.63M |
| Capital Expenditures | -529.14M |
| Free Cash Flow | -669.77M |
| FCF Per Share | -6.36 |
Margins
Gross margin is 84.41%, with operating and profit margins of -14.91% and -16.92%.
| Gross Margin | 84.41% |
| Operating Margin | -14.91% |
| Pretax Margin | -13.99% |
| Profit Margin | -16.92% |
| EBITDA Margin | -10.4% |
| EBIT Margin | -14.91% |
| FCF Margin | -17.58% |
Dividends & Yields
ONC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ONC is $313, which is 35.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $313 |
| Price Target Difference | 35.5% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 5.09 |
| Piotroski F-Score | 5 |